Ana Lucia Relo

This inventor holds 12 USPTO granted patents and 10 published patent applications and 3 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc., Abbott Laboratories Corporation. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Lucia Relo. Retrieved from https://idiyas.com/inventor/ana-lucia-relo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 10)

% Patents Active = 66.7

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 17(Granted Patents)

Company Filing History:

11 out of 167

Abbvie Deutschland Gmbh and Co Kg

Abbott Laboratories Corporation

where one patent can have more than one assignee

Years Active: 2013-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10160744 - [object Object] (2018-12-25),

2. 10118926 - Tricyclic quinoline and quinoxaline derivatives (2018-11-06),

3. 9994568 - Tricyclic quinoline and quinoxaline derivatives (2018-06-12),

4. 9573950 - Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators (2017-02-21),

5. 9540376 - Hexahydrodiazepinoquinolines carrying a substituted alkyl radical (2017-01-10),

6. 9388148 - Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor (2016-07-12),

7. 9388141 - Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor (2016-07-12),

8. 9376396 - Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor (2016-06-28),

9. 9169253 - Tricyclic quinoline and quinoxaline derivatives (2015-10-27),

10. 8772313 - [object Object] (2014-07-08),

11. 8710059 - [object Object] (2014-04-29),

12. 8492540 - [object Object] (2013-07-23),

Title: The Innovative Contributions of Ana Lucia Relo

Introduction

Ana Lucia Relo is a prominent inventor based in Ludwigshafen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the 5-HT receptor. With a total of 12 patents to her name, Relo's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among her latest patents, Relo has developed quinoline compounds that are designed to act as modulators of the 5-HT receptor. These compounds are detailed in her patent claims and descriptions, highlighting their pharmaceutical applications. Additionally, she has worked on tricyclic quinoline and quinoxaline derivatives, which also serve as modulators of the 5-HT receptor. These inventions are aimed at preparing medicaments for the prevention or treatment of conditions that respond to the modulation of this receptor.

Career Highlights

Relo has had a successful career, working with notable companies such as AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovation and development.

Collaborations

Throughout her career, Relo has collaborated with talented individuals, including her coworkers Andreas Haupt and Karla Drescher. These collaborations have likely contributed to her success and the advancement of her innovative projects.

Conclusion

Ana Lucia Relo's contributions to pharmaceutical innovation through her patents and collaborations highlight her role as a significant inventor in her field. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.